By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Boehringer Ingelheim (Canada) Ltd. 

5180 South Service Road

Burlington  Ontario  L7L 5H4  Canada
Phone: 905-639-0333 Fax: 905-681-0194


SEARCH JOBS








Company News
Boehringer Ingelheim (Canada) Ltd. Release: Study Findings Show Tiotropium Respimat®* Well-Tolerated And Effective In Japanese Patients With Symptomatic Asthma 6/19/2014 6:48:43 AM
GIOTRIF® (afatinib) Approved by Health Canada as a Treatment for Patients With Metastatic Adenocarcinoma of the Lung With Activating EGFR Mutation(s) Who Are Tyrosine Kinase Inhibitor Naive 11/8/2013 6:34:33 AM
Boehringer Ingelheim (Canada) Ltd. Release: Video B-Roll Available Via CNW - Stroke Risk is Within Our Control, Despite What Canadians Believe 2/15/2013 9:44:12 AM
Boehringer Ingelheim (Canada) Ltd. Release: Stroke Risk is Within Our Control, Despite What Canadians Believe 2/12/2013 9:09:27 AM
Boehringer Ingelheim (Canada) Ltd. Release: Diabetes Patients and GPs Don't Agree on Most Worrisome Complications of Condition 8/28/2012 10:58:37 AM
Boehringer Ingelheim (Canada) Ltd. Release: Heart-to-Heart: Canadian Adults Wary of Having "The Talk" With their Parent(s) 8/7/2012 12:15:29 PM
Numerate and Boehringer Ingelheim (Canada) Ltd. Form Research Collaboration Based on in silico Drug Design Technology 12/6/2011 7:23:35 AM
Boehringer Ingelheim (Canada) Ltd. Chooses Integrated Hamilton Storage Technologies, Inc. System for Compound Management 10/26/2011 12:49:21 PM
Dalton Pharma Services And Boehringer Ingelheim (Canada) Ltd. Announce the Renewal of Their Chemistry Services Agreement 2/23/2009 9:19:39 AM
Dalton Medicinal Chemistry Partners Achieves Another Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd. 1/23/2008 9:17:10 AM
12
//-->